Eczemus® 0.1 %Ointment (Tacrolimus)

Tacrolimus is first FDA approved steroid free topical preparation for management of Eczema.
Eczemus (Tacrolimus) is a macrolide immunosuppressant produced by streptomyces tsukubaensis. Eczemus (Tacrolimus) inhibits T-lymphocyte activation by first binding to an intracellular protein,FKBP-12. Eczemus (Tacrolimus) has also been shown to inhibit the release of inflammatory mediators from skin mast cells, basophils and eosinophils. Eczemus (Tacrolimus) ointment does not affect collagen synthesis in humans.